Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Accenture
McKinsey
Fuji
Express Scripts

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 8,163,726

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,163,726
Title:Method of inhibiting choroidal neovascularization
Abstract: The present invention relates to compositions and methods for inhibiting unwanted angiogenesis, particularly those of ocular tissues. The treatment, inhibition, and/or prevention of choroidal neovasculature (CNV) is provided, along with an animal model for CNV and imaging techniques that permit the screening of potential agents as anti-angiogenesis and anti-CNV agents.
Inventor(s): Wen; Rong (Bala Cynwyd, PA), Luo; Zhijun (Chestnut Hill, MA), Laties; Alan M. (Philadelphia, PA)
Assignee: University of Pennsylvania (Philadelphia, PA)
Application Number:10/665,203
Patent Claims:see list of patent claims

Details for Patent 8,163,726

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30 ➤ Sign Up University of Pennsylvania (Philadelphia, PA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,163,726

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2004027027 Apr 01, 2004
World Intellectual Property Organization (WIPO) 2004027027 May 21, 2004
United States of America 2005187241 Aug 25, 2005
United States of America 2009036479 Feb 05, 2009
United States of America 2012190705 Jul 26, 2012
United States of America 8618088 Dec 31, 2013
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Queensland Health
Federal Trade Commission
Medtronic
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.